Apollomics, Inc. , a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia.
Apollomics stock last closed at $0.46, down 3.77% from the previous day, and has decreased 88.61% in one year. It has underperformed other stocks in the Biotechnology industry by 0.65 percentage points. Apollomics stock is currently +15% from its 52-week low of $0.40, and -92.87% from its 52-week high of $6.45.
There are currently 89.5M APLM shares outstanding. The market value of APLM is $41.17M. In the last 24 hours, 168,941 APLM shares were traded.
You will need a brokerage account to access the NASDAQ market and buy APLM shares.
We believe that eToro is the best stock brokerage. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal information so you are able to invest in APLM stock today.
Now that you have finished signing up on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing funds into your investment account.
After you have chosen the best place to buy Apollomics stock, it's very important to research their stock before you invest, so you can understand the risk and upside.
WallStreetZen was built to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on APLM's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge APLM's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on APLM's stock here.
Out of 2 sell side analysts who give forecasts on APLM, the consensus analyst rating on Apollomics is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Apollomics stock forecast page.
In the last 12 months, executives and large shareholders at APLM have not bought or sold any shares.
Get more info about who owns APLM shares here.
No, Apollomics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main order types:
Click the Open button and your broker will execute the order.
If you require additional help buying stocks on eToro, watch the how to video below:
Now that you own some APLM shares, you'll want to keep up with your shares.
Put APLM on a watchlist to see the latest developments about your APLM stock.
To reiterate, here are the 6 steps to buy stock in Apollomics:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Apollomics, create your watchlist below.